Progesterone Capsule
Product Images NDC 68788-8709

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 68788-8709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph1 (Figure001)

Graph1 (Figure001)
This appears to be a table showing different medication treatments for conjugated estrogens alone, conjugated estrogens plus micronized progesterone (cyclical), and a placebo over a period of 36 months. The table also includes the number of patients remaining in the study at 12, 24, and 36 months intervals. The data seems to be related to a clinical trial or study.*
FDA Label Image

Progesterone Capsules 100mg (Progesterone Image001 V1)

Progesterone Capsules 100mg (Progesterone Image001 V1)
This text appears to be information related to a medication called Progesterone Capsules 100mg. The capsules contain 100mg of micronized progesterone USP. It mentions caution against transferring the drug to anyone other than the patient it was prescribed for, as per Federal law. The capsules are described as oval, yellow, and imprinted with P. The text also includes storage instructions, warnings, and details about the manufacturer.*
FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.